Additionally, the clear alterations in BC cells’ migration seen at 24 h were further corroborated, with both the untreated 4T1 cells and the siControl transfected cells exhibiting a percentage of wound closure of around 59%, whereas MEF2C-silenced cells had the lowest closure of approximately 37%. The gene discussed is MEF2C; the disease is breast cancer.